Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphodiesterase 6-delta is a soluble protein originally identified as the delta subunit within the rod cell-specific cGMP phosphodiesterase complex involved in visual phototransduction. Beyond its role in vision, it acts as a specific transport factor for certain prenylated proteins—including members of the Ras superfamily—by binding their farnesyl or geranylgeranyl groups and facilitating their intracellular localization. This chaperone function is critical for proper membrane association and signaling activity of these small GTPases. Inhibitors targeting PDE6D’s prenyl-binding pocket can disrupt oncogenic K-Ras trafficking and signaling, making it a potential therapeutic target in cancer. Additionally, modulation of its activity has been implicated in ocular diseases such as glaucoma through effects on intraocular pressure regulation. The protein is widely expressed beyond retinal tissue and participates broadly in cellular processes involving lipid-modified protein transport.
Inhibition of prenyl-binding pocket to block trafficking and function of prenylated proteins such as K-Ras
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphodiesterase 6-delta (PDE6D).